hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
Sgarbossa A and Lenci F Spectroscopic study of visible-light effects on hypericin-lens proteins systems. 2001 Photochem. Photobiol. pmid:11547554
Freeman D et al. The structure of hypericin in solution. Searching for hypericin's 1,6 tautomer. 2001 Photochem. Photobiol. pmid:11547556
Obermüller RA et al. Toward hypericin-derived potential photodynamic therapy agents. 2001 Photochem. Photobiol. pmid:11547557
Wills NJ et al. Tumor cell toxicity of hypericin and related analogs. 2001 Photochem. Photobiol. pmid:11547558
Xie X et al. Tumor-specific and photodependent cytotoxicity of hypericin in the human LNCaP prostate tumor model. 2001 Photochem. Photobiol. pmid:11547559
Bergonzi MC et al. Variability in the content of the constituents of Hypericum perforatum L. and some commercial extracts. 2001 Drug Dev Ind Pharm pmid:11548855
Whiskey E et al. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. 2001 Int Clin Psychopharmacol pmid:11552767
Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil. 2001 Int. J. Toxicol. pmid:11558639
Peebles KA et al. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum). 2001 Biochem. Pharmacol. pmid:11597574
de los Reyes GC and Koda RT Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations. 2001 J Pharm Biomed Anal pmid:11600308
Sloley BD et al. Chemical and pharmacological evaluation of Hypericum perforatum extracts. 2000 Acta Pharmacol. Sin. pmid:11603291
Ali SM et al. Induction of apoptosis by Hypericin through activation of caspase-3 in human carcinoma cells. 2001 Int. J. Mol. Med. pmid:11605021
Jensen AG and Hansen SH Separation of hypericins and hyperforins in extracts of Hypericum perforatum L. using non-aqueous capillary electrophoresis with reversed electro-osmotic flow. 2002 J Pharm Biomed Anal pmid:11682223
Cavarga I et al. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. 2001 Phytomedicine pmid:11695874
Blank M et al. Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. 2000 Oncol. Res. pmid:11697819
Uzdensky AB et al. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. 2001 Lasers Med Sci pmid:11702633
Chan LY et al. A study of hypericin-induced teratogenicity during organogenesis using a whole rat embryo culture model. 2001 Fertil. Steril. pmid:11704142
Hwang MS et al. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin. 2001 Jul-Aug Anticancer Res. pmid:11724334
Perloff MD et al. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. 2001 Br. J. Pharmacol. pmid:11739235
Derycke AS and De Witte PA Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes. 2002 Int. J. Oncol. pmid:11743662
Ekins S and Erickson JA A pharmacophore for human pregnane X receptor ligands. 2002 Drug Metab. Dispos. pmid:11744617
Ali SM et al. Hypericin and hypocrellin induced apoptosis in human mucosal carcinoma cells. 2001 J. Photochem. Photobiol. B, Biol. pmid:11748006
Kiniczky M [Hyperici herba (Hypericum perforatum L]. 2001 Acta Pharm Hung pmid:11769089
Kamuhabwa AA et al. Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. 2002 Int. J. Cancer pmid:11774272
Rayburn WF et al. Impact of hypericum (St.-John's-wort) given prenatally on cognition of mice offspring. Neurotoxicol Teratol pmid:11792531
Poutaraud A et al. Improved procedure for the quality control of Hypericum perforatum L. 2001 Nov-Dec Phytochem Anal pmid:11793812
Tekel'ová D and Mrlianová M [Experimental cultivation of Hypericum perforatum L. in Bratislava]. 2001 Ceska Slov Farm pmid:11797201
Johne A et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ). 2002 J Clin Psychopharmacol pmid:11799342
Bauer S et al. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection. 2001 J. Chromatogr. B Biomed. Sci. Appl. pmid:11817306
Klier CM et al. St. John's wort (Hypericum perforatum)--is it safe during breastfeeding? 2002 Pharmacopsychiatry pmid:11819157
Mirossay A et al. The effect of quercetin on light-induced cytotoxicity of hypericin. 2001 Physiol Res pmid:11829327
Pytel A and Schmeller N New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology. 2002 Urology pmid:11834388
Agostinis P et al. Hypericin in cancer treatment: more light on the way. 2002 Int. J. Biochem. Cell Biol. pmid:11849990
Varriale L et al. Molecular aspects of photodynamic therapy: low energy pre-sensitization of hypericin-loaded human endometrial carcinoma cells enhances photo-tolerance, alters gene expression and affects the cell cycle. 2002 FEBS Lett. pmid:11852097
Chen B et al. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. 2002 Int. J. Cancer pmid:11857421
Tolonen A et al. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. 2002 Rapid Commun. Mass Spectrom. pmid:11857723
Schempp CM et al. Phototoxic and apoptosis-inducing capacity of pseudohypericin. 2002 Planta Med. pmid:11859473
Butterweck V et al. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. 2002 Brain Res. pmid:11879791
Bray BJ et al. Short term treatment with St. John's wort, hypericin or hyperforin fails to induce CYP450 isoforms in the Swiss Webster mouse. 2002 Life Sci. pmid:11883710
Miskovsky P Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. 2002 Curr Drug Targets pmid:11899265
de los Reyes GC and Koda RT Determining hyperforin and hypericin content in eight brands of St. John's wort. 2002 Am J Health Syst Pharm pmid:11908248
Smelcerovic A et al. The separation of hypericine and pseudohypericine from Hypericum perforatum L. 2002 Pharmazie pmid:11933846
Zhao J et al. [Studies on synthesis and anti-HIV RT activity of hypericin and ethylhypericin]. 1998 Yao Xue Xue Bao pmid:11938940
Ali SM et al. Hypocrellins and Hypericin induced apoptosis in human tumor cells: a possible role of hydrogen peroxide. 2002 Int. J. Mol. Med. pmid:11956650
Mirossay A et al. Potentiation of hypericin and hypocrellin-induced phototoxicity by omeprazole. 1999 Phytomedicine pmid:11962536
D'Hallewin MA et al. Hypericin-based fluorescence diagnosis of bladder carcinoma. 2002 BJU Int. pmid:11966641
Cotterill JA Severe phototoxic reaction to laser treatment in a patient taking St John's Wort. 2001 J Cosmet Laser Ther pmid:12006194
Langosch JM et al. St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors. 2002 Eur Neuropsychopharmacol pmid:12007672
Ali SM et al. Hypericin induced death receptor-mediated apoptosis in photoactivated tumor cells. 2002 Int. J. Mol. Med. pmid:12011977
Hritz J et al. Influence of structure of human, rat, and bovine serum albumins on binding properties of photoactive drug hypericin. 2002 Biopolymers pmid:12012440
Walker TS et al. Jasmonic acid-induced hypericin production in cell suspension cultures of Hypericum perforatum L. (St. John's wort). 2002 Phytochemistry pmid:12031448
Du H et al. Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy. 2002 Int. J. Mol. Med. pmid:12060853
Morrey JD et al. Identification of active antiviral compounds against a New York isolate of West Nile virus. 2002 Antiviral Res. pmid:12076755
von Eggelkraut-Gottanka SG et al. Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John's Wort). 2002 May-Jun Phytochem Anal pmid:12099108
Vantieghem A et al. Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. 2002 J. Biol. Chem. pmid:12101183
Droller MJ Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy. 2002 J. Urol. pmid:12134841
Shin I et al. Thermal denaturation of Bungarus fasciatus acetylcholinesterase: Is aggregation a driving force in protein unfolding? 2002 Protein Sci. pmid:12142456
Solár P et al. Effect of acetazolamide on hypericin photocytotoxicity. 2002 Planta Med. pmid:12143007
Ali SM and Olivo M Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. 2002 Int. J. Oncol. pmid:12168096
Wen J et al. Toward the molecular flashlight: preparation, properties, and photophysics of a hypericin-luciferin tethered molecule. 2002 Photochem. Photobiol. pmid:12194210
Romerio F and Zella D MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. 2002 FASEB J. pmid:12206994
Chen B et al. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia. 2002 Lasers Surg Med pmid:12224088
Wirz A et al. Solubility of hypericin in methanol and methanol-pyridine. 2002 Pharmazie pmid:12227194
Siepmann M et al. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. 2002 Br J Clin Pharmacol pmid:12236848
Gertsch J et al. Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds. 2002 Pharm. Res. pmid:12240952
Pirker R et al. Simultaneous determination of hypericin and hyperforin in human plasma and serum using liquid-liquid extraction, high-performance liquid chromatography and liquid chromatography-tandem mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12270208
Wierrani F et al. Photodynamic action of some sensitizers by photooxidation of luminol. 2002 Naturwissenschaften pmid:12384722
Conforti F et al. Antioxidant activity of methanolic extract of Hypericum triquetrifolium Turra aerial part. 2002 Fitoterapia pmid:12385870
Widy-Tyszkiewicz E et al. Long term administration of Hypericum perforatum improves spatial learning and memory in the water maze. 2002 Biol. Pharm. Bull. pmid:12392080
Uzdensky AB et al. Photobleaching of hypericin bound to human serum albumin, cultured adenocarcinoma cells and nude mice skin. 2002 Photochem. Photobiol. pmid:12403454
Blank M et al. Wavelength-dependent properties of photodynamic therapy using hypericin in vitro and in an animal model. 2002 Photochem. Photobiol. pmid:12403456
D'Hallewin MA et al. Fluorescence detection of bladder cancer: a review. 2002 Eur. Urol. pmid:12429148
Chen B et al. Antivascular tumor eradication by hypericin-mediated photodynamic therapy. 2002 Photochem. Photobiol. pmid:12462645
Murch SJ et al. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem). 2002 Planta Med. pmid:12494339
von Eggelkraut-Gottanka SG et al. Roller compaction and tabletting of St. John's wort plant dry extract using a gap width and force controlled roller compactor. I. Granulation and tabletting of eight different extract batches. 2002 Pharm Dev Technol pmid:12503525
Simmen U et al. Antagonist effect of pseudohypericin at CRF1 receptors. 2003 Eur. J. Pharmacol. pmid:12504780
Mirossay A et al. Modulation of the phototoxic effect of hypericin in human leukemia CEM cell line by N-ethylmaleimide, amiloride and omeprazole. 2002 Physiol Res pmid:12511190
Glisson JK et al. Clinic at the health food store? Employee recommendations and product analysis. 2003 Pharmacotherapy pmid:12523461
Rahimipour S et al. Chemical and photochemical electron transfer of new helianthrone derivatives: aspects of their photodynamic activity. 2003 J. Am. Chem. Soc. pmid:12553841
Gao Q et al. Effect of hypericin on confocal imaging of Ca2+ signaling in cultured human retinal pigment epithelium. 2001 Yan Ke Xue Bao pmid:12567741
Schmitt J [Dangerous interaction of St. John's wort with chemotherapy?]. 2003 Pharm Unserer Zeit pmid:12577753
Schempp CM et al. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation. 2003 Phytother Res pmid:12601676
Schmidt AH Use of an on-line, precolumn photochemical reactor in high-performance liquid chromatography of naphthodianthrones in Hypericum perforatum preparations. 2003 J Chromatogr A pmid:12613810
Kaltschmidt B et al. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. 2002 Neuromolecular Med. pmid:12622408
Ali SM and Olivo M Nitric oxide mediated photo-induced cell death in human malignant cells. 2003 Int. J. Oncol. pmid:12632064
Kamuhabwa AA et al. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation. 2003 Int. J. Oncol. pmid:12632090
Siboni G et al. The correlation between hydrophilicity of hypericins and helianthrone: internalization mechanisms, subcellular distribution and photodynamic action in colon carcinoma cells. 2002 Photochem. Photobiol. Sci. pmid:12659159
Piperopoulos G et al. [Methyl-D3]2hypericin as internal standard for quantification in human plasma. 2003 Anal Bioanal Chem pmid:12664172
Taher MM et al. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light. 2002 IUBMB Life pmid:12665247
Höpfner M et al. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. 2003 Int J Colorectal Dis pmid:12673490
Butterweck V et al. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats. 2003 Planta Med. pmid:12677519
Du HY et al. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. 2003 Int. J. Oncol. pmid:12684667
Jürgenliemk G and Nahrstedt A Dissolution, solubility and cooperativity of phenolic compounds from Hypericum perforatum L. in aqueous systems. 2003 Pharmazie pmid:12685814
Chen TC et al. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma. 2003 Cancer pmid:12712458
Ali SM and Olivo M Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review). 2003 Int. J. Oncol. pmid:12738982
Butterweck V et al. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. 2003 Life Sci. pmid:12770617
Xu MS et al. [Induction of callus of Hypericum perforatum L. and qualitative identification of active constituents of its callus]. 2001 Zhongguo Zhong Yao Za Zhi pmid:12776326
Schmidt PC [Formulation of St. John's wort extract. A medicinal obstacle course]. 2003 Pharm Unserer Zeit pmid:12784540
Cakir A et al. Isolation and characterization of antioxidant phenolic compounds from the aerial parts of Hypericum hyssopifolium L. by activity-guided fractionation. 2003 J Ethnopharmacol pmid:12787957
Bais HP et al. Molecular and biochemical characterization of an enzyme responsible for the formation of hypericin in St. John's wort (Hypericum perforatum L.). 2003 J. Biol. Chem. pmid:12799379